The company will prove that its vaccine will be effective against coronavirus mutations
Moderna mRNA vaccine against COVID-19 is likely to provide protection for about two years, as its CEO stated today, although more data is needed to make a definitive assessment.
The American biotechnology company, which last year surprised the whole world as it developed a vaccine against the disease caused by the new coronavirus in just a few weeks, received yesterday the approval from the European Commission for its vaccine.
As vaccine development and pharmacovigilance usually take years, the duration of COVID-19 vaccine protection is a question that continues to concern scientists and regulators, as noted by AMPE.
"The nightmare scenario described in the media in the spring, with a vaccine that will only work for a month or two, he's got, I think so, dissapeared", said Moderna CEO Stefan Bancel at an event organized by the financial services group Oddo BHF.
"The immune response produced in the human body is declining very slowly ουμε We believe that there will potentially be protection for about two years".
Bancell added that his company was going to prove that its vaccine would also be effective against coronavirus mutations found in Britain and South Africa..
According to scientists, newly developed vaccines are expected to be equally effective against both of these mutations.